about
Human papillomavirus DNA prevalence and type distribution in anal carcinomas worldwide.HPV Involvement in Head and Neck Cancers: Comprehensive Assessment of Biomarkers in 3680 Patients.Poor Cervical Cancer Screening Attendance and False Negatives. A Call for Organized Screening.Human Papillomavirus Genotype Distribution in Invasive Cervical Cancer in PakistanBasaloid squamous cell carcinoma of the penis with papillary features: a clinicopathologic study of 12 cases.HPV prevalence and genotypes in different histological subtypes of cervical adenocarcinoma, a worldwide analysis of 760 cases.Human papillomavirus distribution in invasive cervical carcinoma in sub-Saharan Africa: could HIV explain the differences?Time trends of human papillomavirus types in invasive cervical cancer, from 1940 to 2007.Performance of careHPV for detecting high-grade cervical intraepithelial neoplasia among women living with HIV-1 in Burkina Faso and South Africa: HARP study.Role of Human Papillomavirus in Penile Carcinomas Worldwide.Disagreement in high-grade/low-grade intraepithelial neoplasia and high-risk/low-risk HPV infection: clinical implications for anal cancer precursor lesions in HIV-positive and HIV-negative MSM.Large contribution of human papillomavirus in vaginal neoplastic lesions: a worldwide study in 597 samples.The basaloid cell is the best tissue marker for human papillomavirus in invasive penile squamous cell carcinoma: a study of 202 cases from Paraguay.Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study.Distinctive association of p16INK4a overexpression with penile intraepithelial neoplasia depicting warty and/or basaloid features: a study of 141 cases evaluating a new nomenclature.Human papillomavirus genotype distribution in invasive cervical cancer in Bosnia and Herzegovina.Value of p16(INK)⁴(a) in the pathology of invasive penile squamous cell carcinomas: A report of 202 cases.Human papillomavirus genotype distribution in cervical cancer cases in Spain. Implications for prevention
P50
Q34731530-DCF3C92B-5C0D-4E30-8ADD-E06B926E2AAAQ35908027-B5B621DA-1291-472B-B3CE-0543ACE77446Q36108910-FBCCF3AC-3BDC-4E94-B12A-0F71B07E7756Q37208823-51E3E9DE-D139-4EBB-AA5C-40FBF8D26CCCQ37988374-3AD0C38B-F8CE-4404-B852-9BAEBD62A8F6Q38206887-5CAB836C-B21A-40F3-B27A-248E20E3BF16Q38866908-E8921EEE-DBF0-44A6-9991-EDE579F1C564Q39281387-7670FCC0-4ED7-42EF-AFFB-77970138C7FDQ39443867-BF8D0701-1516-4CDD-AC27-97487AEF3185Q40980612-E9D66309-FE57-4926-B11C-0710D1D6C793Q41472768-B294641A-7A73-4966-A530-3044F0B3FD6CQ42198069-FFF75041-A0DB-484B-A751-BC48A985EB24Q44558215-D141D0B6-8683-434F-9802-E02A09C68608Q45206974-CA7D286C-F830-489B-97C4-931FC7D53F2CQ48664112-3999A029-21E9-42D8-849E-47630A8963FDQ50644081-72415275-E44C-4605-91C5-25197907C6C3Q54391223-58092CDB-1F60-4E25-9376-D17457828BD6Q56839491-E9197C68-89F8-431E-97A0-1F868CB85BE0
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Omar Clavero
@ast
Omar Clavero
@en
Omar Clavero
@es
Omar Clavero
@nl
Omar Clavero
@sl
type
label
Omar Clavero
@ast
Omar Clavero
@en
Omar Clavero
@es
Omar Clavero
@nl
Omar Clavero
@sl
prefLabel
Omar Clavero
@ast
Omar Clavero
@en
Omar Clavero
@es
Omar Clavero
@nl
Omar Clavero
@sl
P106
P21
P31
P496
0000-0001-9721-6382